WBP-3425

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameWBP-3425
Drug Alias NameWBP-3425
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionHepatitis A virus cellular receptor 2 inhibitors
TargetsHepatitis A virus cellular receptor 2
Therapy Area/IndicationsSolid tumoursColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi BioCity
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWuxi BioCity
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A